Corteva Q2 Beats on Seed, Cuts Outlook on Weaker Crop Chems

Corteva beat second-quarter estimates on stronger seed sales but cut its full-year outlook as its crop protection business grapples with weak demand and pricing pressure.

The company reported adjusted earnings of $1.82 a share for the quarter ended June 30, topping the $1.74 consensus compiled by Bloomberg. Net sales fell 2% to $6.14 billion, roughly in line with expectations.

Corteva now sees full-year adjusted operating earnings of $3.40 to $3.60 a share, down from a prior range of $3.60 to $3.80. The revised guidance implies a weaker second half, particularly for the crop protection unit, which has been hit by destocking and lower commodity prices.

Seed was the bright spot. Seed net sales rose 3% to $4.13 billion, driven by higher volumes in North America and Latin America. The unit's operating earnings before special items increased 8% to $1.22 billion. Judd O'Connor, who runs the seed business, said on the call that the company gained share in corn and soybeans in both regions.

Crop protection was the drag. Net sales in that segment fell 12% to $2.01 billion. Volume declined 7% and price dropped 5%, reflecting what CEO Chuck Magro called a "challenging demand environment" globally. The unit's operating earnings before special items plunged 35% to $456 million.

Magro said the company is cutting costs in crop protection, including a headcount reduction and plant closures, but he did not give specific numbers. The unit is also pulling back on inventory builds for the second half, which contributed to the guidance cut.

Corteva's overall operating earnings before special items for the quarter were $1.01 billion, down 9% from a year earlier. Gross margin contracted 120 basis points to 42.8%, partly on unfavorable mix toward lower-margin seed.

The company generated $1.4 billion in operating cash flow in the first half, up from $1.1 billion a year earlier. Free cash flow was $1.1 billion. Corteva ended the quarter with $1.8 billion in cash and $3.6 billion in total debt.

Morgan Stanley's Vincent Andrews asked on the call how much of the guidance cut was conservatism versus real deterioration. Magro said the second half is "more uncertain than normal" and that the company is being "prudent" but not aggressive in its assumptions.

RBC Capital's Arun Viswanathan asked about seed pricing for the 2027 season. O'Connor said pricing is expected to be "modestly positive" but competitive, especially in soybeans where acreage is expected to rise.

Corteva's Alpha Score sits at 55 out of 100, a Mixed rating, according to AlphaScala's proprietary model. The score reflects the split between a resilient seed franchise and a struggling crop protection business that has yet to find a bottom.

The company's stock page is at CTVA stock page.

Corteva did not announce a share buyback or dividend increase. The board authorized a new $1.5 billion buyback program in February, and the company has $800 million remaining under it.

The crop protection restructuring is expected to yield $200 million to $250 million in annual savings by 2028, with about half hitting in 2027, the company said. Most of the savings come from manufacturing consolidation and procurement, not R&D cuts.

Magro said the strategic review of the crop protection portfolio, including potential divestitures, is ongoing. He declined to give a timeline.